Federal contract award
75A50119C00059
CMC EFFORTS FOR MAB114 DEVELOPMENT FOR THE TREATMENT OF EBOLA.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541713 — Research and Development in Nanotechnology |
| PSC | AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $14.0M |
| Current contract value | $14.0M |
| Potential contract value / ceiling | $14.0M |
| Start date | Sep 5, 2019 |
| Current end date | Dec 31, 2020 |
| Potential end date | Dec 31, 2020 |
| Latest award activity | Aug 15, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 15, 2025 | P00009 | $0 | ADDITIONAL IN-SCOPE WORK FOR CMC EFFORTS FOR MAB114 DEVELOPMENT FOR THE TREATMENT OF EBOLA. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.